Latest & greatest articles for babies

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on babies or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on babies and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for babies

21. Domperidone increases breast milk production in mothers of premature babies

Domperidone increases breast milk production in mothers of premature babies Domperidone increases breast milk in mothers of premature babies Discover Portal Discover Portal Domperidone increases breast milk production in mothers of premature babies Published on 8 May 2018 doi: The drug domperidone increases the amount of breast milk women produce. This review looked at its use for up to two weeks in women with premature babies being fed with expressed milk. Women had a moderate increase (...) in breast milk of about 88ml a day, a clinically important increase for these small babies. Domperidone is an anti-sickness medication. It has not been widely used to increase breast milk because of unknown effectiveness and concerns that it can cause an irregular heart rhythm with longer-term use in older people. This review found it can moderately increase milk production. Though no serious or cardiac side effects occurred in the studies, only 192 women participated in the trials, so rarer side

2019 NIHR Dissemination Centre

22. Premature babies have fewer complications if a lower platelet count is accepted

Premature babies have fewer complications if a lower platelet count is accepted Premature babies have fewer complications if a lower platelet count is accepted Discover Portal Discover Portal Premature babies have fewer complications if a lower platelet count is accepted Published on 22 January 2019 doi: Fewer premature babies die or have major bleeding if platelet transfusions are withheld until platelet numbers drop to a lower level. At 28 days, death or new major bleeding occurred in 19 (...) % of neonates transfused when they had less than 25,000/mm 3 platelets compared to 26% of neonates transfused when they had less than 50,000/mm 3 platelets. This trial included 660 premature babies with low platelet counts. The results suggest that in the absence of actual bleeding, platelet transfusions may be safer to give when blood platelet concentrations are lower than currently recommended trigger thresholds. It remains unclear why there was an increased risk of the combined outcome of either death

2019 NIHR Dissemination Centre

23. A new method for monitoring baby’s heart beat during labour probably not justified

A new method for monitoring baby’s heart beat during labour probably not justified A new method for monitoring baby’s heart beat during labour probably not justified Discover Portal Discover Portal A new method for monitoring baby’s heart beat during labour probably not justified Published on 1 March 2016 doi: A new way of monitoring a baby’s distress during labour, called ST waveform analysis, did not improve outcomes for the baby or reduce the likelihood of a caesarean section compared (...) to current practice. Although monitoring of babies’ heartbeats during labour is common practice in the UK, additional ST analysis is not commonly used and on the basis of this evidence probably should not be promoted for routine use yet. The outcomes measured in this review included death of the baby before or after birth, fits and brain damage from low oxygen levels. Finding babies at risk of these rare events is important as urgent delivery may save the baby. However if there is a role for ST analysis

2019 NIHR Dissemination Centre

24. Kangaroo mother care may boost the survival of newborn, premature babies

Kangaroo mother care may boost the survival of newborn, premature babies Kangaroo mother care may boost the survival of newborn, premature babies Discover Portal Discover Portal Kangaroo mother care may boost the survival of newborn, premature babies Published on 23 February 2016 doi: Kangaroo mother care reduced the death rate of newborns by around a quarter compared with conventional care, according to a review of studies from around the world. Other positive outcomes included lower risk (...) of neonatal sepsis, hypothermia, hypoglycaemia, hospital readmission and higher exclusive breast feeding rates. Kangaroo care definitions vary by study, but typically promote mother and baby skin-to-skin contact, sometimes in combination with other elements like promoting breast feeding, and early supported discharge from hospital. Most of the studies in this review looked at premature babies born before 37 weeks and some studies were in low or middle income countries. Prolonged skin-to-skin contact

2019 NIHR Dissemination Centre

25. The clinical effectiveness of non-invasive high frequency oscillation ventilation (NHFOV) vs nasal continuous positive airway pressure (nCPAP) for preterm babies with respiratory distress syndrome

The clinical effectiveness of non-invasive high frequency oscillation ventilation (NHFOV) vs nasal continuous positive airway pressure (nCPAP) for preterm babies with respiratory distress syndrome Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears

2019 PROSPERO

26. Incidence of babies eligible for screening for neonatal hypoglycaemia

Incidence of babies eligible for screening for neonatal hypoglycaemia Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

27. Prevalence of postpartum depression in women delivering a baby girl: a systematic review

Prevalence of postpartum depression in women delivering a baby girl: a systematic review Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

28. Improving babies', children's and young people's experience of the healthcare environment

Improving babies', children's and young people's experience of the healthcare environment Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites

2019 PROSPERO

29. Barriers to, and facilitators of, continuity of healthcare for babies, children and young people

Barriers to, and facilitators of, continuity of healthcare for babies, children and young people Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external

2019 PROSPERO

30. Babies', children's, and young people's access to healthcare services

Babies', children's, and young people's access to healthcare services Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

31. Babies', children's and young people's access to healthcare information

Babies', children's and young people's access to healthcare information Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. The registrant confirms that the information supplied for this submission is accurate and complete. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation

2019 PROSPERO

32. A trial of probiotics for treating sepsis in very premature babies poses more questions than it answers

A trial of probiotics for treating sepsis in very premature babies poses more questions than it answers A trial of probiotics for treating sepsis in very premature babies poses more questions than it answers Discover Portal Discover Portal A trial of probiotics for treating sepsis in very premature babies poses more questions than it answers Published on 23 December 2015 doi: Contrary to a previous review of trials, this large, NIHR-funded trial found that probiotic treatment did not prevent (...) two common life-threatening conditions in very premature babies. The conditions were necrotising enterocolitis, which is a severe gut inflammation/infection that can result in the death of intestinal tissue, and sepsis (blood poisoning) from bacteria that have crossed from the gut into the bloodstream. This trial used a single strain of a harmless bacterium, known as a “probiotic”, prepared to high quality standards fit for medicines, and chosen because it is commonly used in dietary supplements

2018 NIHR Dissemination Centre

33. Servo-n with Neurally Adjusted Ventilatory Assist (NAVA) for babies and children

Servo-n with Neurally Adjusted Ventilatory Assist (NAVA) for babies and children Serv Servo-n with Neur o-n with Neurally Adjusted V ally Adjusted Ventilatory entilatory Assist (NA Assist (NAV VA) for babies and children A) for babies and children Medtech innovation briefing Published: 26 October 2018 nice.org.uk/guidance/mib163 pathways Summary Summary The technology technology described in this briefing is the Servo-n with Neurally Adjusted Ventilatory Assist (NAVA). It is used for babies (...) in therapy is uncertain. The main points from the e main points from the evidence vidence summarised in this briefing are from 4 studies, including 2 randomised controlled crossover trials, 1 randomised controlled trial (RCT) and 1 systematic review involving a total of 415 babies and children in paediatric and neonatal intensive care units. The systematic review and 1 RCT showed that Servo-n with NAVA improved patient- ventilator synchrony. K Ke ey uncertainties y uncertainties around the technology

2018 National Institute for Health and Clinical Excellence - Advice

34. Heated, humidified high-flow oxygen therapy may be a useful alternative to other forms of respiratory support for preterm babies

Heated, humidified high-flow oxygen therapy may be a useful alternative to other forms of respiratory support for preterm babies Heated, humidified high-flow oxygen therapy may be a useful alternative to other forms of respiratory support for preterm babies Discover Portal Discover Portal Heated, humidified high-flow oxygen therapy may be a useful alternative to other forms of respiratory support for preterm babies Published on 7 December 2015 doi: This review found that heated, humidified high (...) -flow oxygen therapy by nose was a safe and effective alternative to other non-invasive methods for supporting breathing for preterm babies. It was less likely to cause nasal injury compared with other methods that used nose tubes. Oxygen therapy is commonly used as a form of breathing support for preterm babies with respiratory distress syndrome, a common complication of premature delivery that makes it hard for a baby to breathe. High-flow therapy may therefore be used instead of mechanical

2018 NIHR Dissemination Centre

35. Interventions to reduce unnecessary caesarean sections in healthy women and babies. (PubMed)

Interventions to reduce unnecessary caesarean sections in healthy women and babies. Optimising the use of caesarean section (CS) is of global concern. Underuse leads to maternal and perinatal mortality and morbidity. Conversely, overuse of CS has not shown benefits and can create harm. Worldwide, the frequency of CS continues to increase, and interventions to reduce unnecessary CSs have shown little success. Identifying the underlying factors for the continuing increase in CS use could improve

2018 Lancet

36. Inhaling a saline mist did not reduce the time in hospital for babies with bronchiolitis

Inhaling a saline mist did not reduce the time in hospital for babies with bronchiolitis Inhaling a saline mist did not reduce the time in hospital for babies with bronchiolitis Discover Portal Discover Portal Inhaling a saline mist did not reduce the time in hospital for babies with bronchiolitis Published on 28 October 2015 doi: In this NIHR-funded trial babies with a viral chest infection (acute bronchiolitis) were treated either with a strong saline mist (nebulised 3% hypertonic sodium (...) chloride) with standard care or standard care alone. The stronger than usual, hypertonic saline mist had no effect on the time it took for babies to be ready for discharge, nor did the trial demonstrate any other benefit from its use. The treatment itself caused some minor side effects in a few babies, such as excessive coughing and a fall in blood oxygen levels. It was also not cost-effective at usual NHS thresholds. The results of the trial should be directly relevant to the UK context. The authors

2018 NIHR Dissemination Centre

37. Giving obese pregnant women metformin had no effect on baby’s weight at birth

Giving obese pregnant women metformin had no effect on baby’s weight at birth Giving obese pregnant women metformin had no effect on baby’s weight at birth Discover Portal Discover Portal Giving obese pregnant women metformin had no effect on baby’s weight at birth Published on 15 September 2015 doi: A large trial found that giving obese pregnant women the diabetes drug, metformin, to prevent heavier babies, had no effect compared with an inactive dummy tablet. The trial was funded by the NIHR (...) and Medical Research Council, and was the first to give metformin, a diabetes drug that is safe in pregnancy, to pregnant women without type 2 diabetes for this purpose. There are theoretical reasons why the medication may help in reducing a baby’s birthweight and previous studies had shown links between higher glucose levels in mother’s blood and larger babies. Participants received either standard doses of metformin or the inactive tablet from about 12 weeks of a mother’s pregnancy to a baby’s birth

2018 NIHR Dissemination Centre

38. Effect of partograph use on outcomes for women in spontaneous labour at term and their babies. (PubMed)

Effect of partograph use on outcomes for women in spontaneous labour at term and their babies. The partograph (sometimes known as partogram) is usually a pre-printed paper form on which labour observations are recorded. The aim of the partograph is to provide a pictorial overview of labour, and to alert midwives and obstetricians to deviations in maternal or fetal well-being and labour progress. Charts have traditionally contained pre-printed alert and action lines. An alert line, which

2018 Cochrane

39. Babies

Babies Top results for babies - Trip Database or use your Google+ account Find evidence fast ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4) Loading (...) history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for babies The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest

2018 Trip Latest and Greatest

40. New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir

New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir | European Medicines Agency Search Search Menu New study suggests risk of birth defects in babies born to women on HIV medicine dolutegravir Press release 18/05/2018 While EMA review is ongoing, dolutegravir should not be used in women seeking to become pregnant The European Medicines Agency (EMA (...) ) is evaluating preliminary results from a study which found 4 cases of birth defects such as spina bifida (malformed spinal cord) in babies born to mothers who became pregnant while taking dolutegravir. While EMA is assessing the new evidence it has issued the following precautionary advice: Dolutegravir HIV medicines should not be prescribed to women seeking to become pregnant. Women who can become pregnant should use effective contraception while taking dolutegravir medicines. The study, which looked

2018 European Medicines Agency - EPARs